Heron Therapeutics
HRTX
HRTX
180 hedge funds and large institutions have $1.69B invested in Heron Therapeutics in 2019 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 73 increasing their positions, 39 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
3% less capital invested
Capital invested by funds: $1.74B → $1.69B (-$52.9M)
3.99% less ownership
Funds ownership: 118.54% → 114.55% (-4%)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
180
Holding in Top 10
2
Calls
$8.62M
Puts
$5.82M
Top Buyers
| 1 | +$18.7M | |
| 2 | +$13.7M | |
| 3 | +$7.67M | |
| 4 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$7.34M |
| 5 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
+$6.25M |
Top Sellers
| 1 | -$26.7M | |
| 2 | -$25M | |
| 3 | -$23.7M | |
| 4 |
BC
Broadfin Capital
New York
|
-$10.4M |
| 5 |
SI
Sofinnova Investments
Menlo Park,
California
|
-$9.5M |